Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks?

A panel of the American Heart Association, the American Cancer Society, and the American Urological Association issued a statement on androgen-deprivation therapy and cardiovascular risk. We’ve got an interview with the chair of the writing committee, Dr. Glenn Levine.

Interview-related links:

• Physician’s First Watch coverage of the statement
• Link to the statement, as published in Circulation

News-related links:

• Lancet retracts 1998 paper linking MMR vaccination and autism
• Use prefilled Sanofi Pasteur N1N1 vaccines before mid-February
• JAMA study on proteinuria

If you’d like to contact Clinical Conversations, call 1-617-440-4374 or write to jelia@jwatch.org

The post Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks? first appeared on Clinical Conversations.